Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.

Park YM, Cho JH, Kang SG, Choi JE, Lee SH, Kim L, Lee HJ.

J Clin Pharm Ther. 2008 Feb;33(1):55-60. doi: 10.1111/j.1365-2710.2008.00872.x.

PMID:
18211617
2.

HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.

Ma X, Maimaitirexiati T, Zhang R, Gui X, Zhang W, Xu G, Hu G.

Int J Psychiatry Clin Pract. 2014 Oct;18(4):229-42. doi: 10.3109/13651501.2014.957705. Epub 2014 Sep 18.

PMID:
25152019
3.

-759C÷T polymorphism of the HTR2C gene is not correlated with atypical antipsychotics-induced weight gain, among Romanian psychotic patients.

Grădinaru RC, Andreescu NI, Nussbaum LA, Farcaş SS, Dumitraşcu V, Suciu L, Puiu M.

Rom J Morphol Embryol. 2016;57(4):1343-1349.

4.

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.

Ujike H, Nomura A, Morita Y, Morio A, Okahisa Y, Kotaka T, Kodama M, Ishihara T, Kuroda S.

J Clin Psychiatry. 2008 Sep;69(9):1416-22.

PMID:
19193342
5.

Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.

Godlewska BR, Olajossy-Hilkesberger L, Ciwoniuk M, Olajossy M, Marmurowska-Michałowska H, Limon J, Landowski J.

Pharmacogenomics J. 2009 Aug;9(4):234-41. doi: 10.1038/tpj.2009.18. Epub 2009 May 12.

PMID:
19434072
6.

Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment.

Park YM, Chung YC, Lee SH, Lee KJ, Kim H, Byun YC, Lim SW, Paik JW, Lee HJ.

Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):394-7.

PMID:
16583406
7.

-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.

Ryu S, Cho EY, Park T, Oh S, Jang WS, Kim SK, Lee D, Hong KS.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):673-7. Epub 2007 Jan 12.

PMID:
17275977
8.

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine.

Ellingrod VL, Perry PJ, Ringold JC, Lund BC, Bever-Stille K, Fleming F, Holman TL, Miller D.

Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):76-8.

PMID:
15666332
9.
10.

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals.

Theisen FM, Hinney A, Brömel T, Heinzel-Gutenbrunner M, Martin M, Krieg JC, Remschmidt H, Hebebrand J.

Psychiatr Genet. 2004 Sep;14(3):139-42.

PMID:
15318026
11.

[Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].

Zhang Z, Zhang X, Yao Z, Chen J, Sun J, Yao H, Hou G, Zhang X, Reynolds GP.

Zhonghua Yi Xue Za Zhi. 2002 Aug 25;82(16):1097-101. Chinese.

PMID:
12425817
12.

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism.

Miller DD, Ellingrod VL, Holman TL, Buckley PF, Arndt S.

Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):97-100.

PMID:
15635667
13.

-759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia.

Daray FM, Rodante D, Carosella LG, Silva ME, Martínez M, Fernández Busch MV, Faccone DF, Rothlin RP, Maffía PC.

Pharmacopsychiatry. 2017 Jan;50(1):14-18. doi: 10.1055/s-0042-110321. Epub 2016 Jul 14.

PMID:
27414739
14.

Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.

Gunes A, Melkersson KI, Scordo MG, Dahl ML.

J Clin Psychopharmacol. 2009 Feb;29(1):65-8. doi: 10.1097/JCP.0b013e31819302c3.

PMID:
19142110
15.

Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain.

Buckland PR, Hoogendoorn B, Guy CA, Smith SK, Coleman SL, O'Donovan MC.

Am J Psychiatry. 2005 Mar;162(3):613-5.

PMID:
15741483
16.

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.

Houston JP, Kohler J, Bishop JR, Ellingrod VL, Ostbye KM, Zhao F, Conley RR, Poole Hoffmann V, Fijal BA.

J Clin Psychiatry. 2012 Aug;73(8):1077-86. doi: 10.4088/JCP.11m06916.

PMID:
22967772
17.

Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.

Kang SG, Lee HJ, Park YM, Choi JE, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):160-3. Epub 2007 Aug 14.

PMID:
17804136
18.

Genetic predictors of antipsychotic-induced weight gain: a case-matched multi-gene study.

Wu R, Zhao J, Shao P, Ou J, Chang M.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Aug;36(8):720-3. doi: 10.3969/j.issn.1672-7347.2011.08.003.

19.

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.

De Luca V, Müller DJ, Hwang R, Lieberman JA, Volavka J, Meltzer HY, Kennedy JL.

Hum Psychopharmacol. 2007 Oct;22(7):463-7.

PMID:
17702092
20.

Polymorphisms of the leptin and HTR2C genes and clozapine-induced weight change and baseline BMI in patients with chronic schizophrenia.

Kang SH, Lee JI, Han HR, Soh M, Hong JP.

Psychiatr Genet. 2014 Dec;24(6):249-56. doi: 10.1097/YPG.0000000000000053.

PMID:
25304226

Supplemental Content

Support Center